REFERENCES
- Wolfs RC, Borger PH, Ramrattan RS, et al. Changing views on open-angle glaucoma: definitions and prevalences − The Rotterdam Study. Invest Ophthalmol Vis Sci 2000;41(11):3309–3321.
- Garway-Heath DF, Ruben ST, Viswanathan A, Hitchings RA. Vertical cup/disc ratio in relation to optic disc size: its value in the assessment of the glaucoma suspect. Br J Ophthalmol 1998;82(10):1118–1124.
- Foster PJ, Oen FT, Machin D, et al. The prevalence of glaucoma in Chinese residents of Singapore: a cross-sectional population survey of the Tanjong Pagar district. Arch Ophthalmol 2000;118(8):1105–1111.
- Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol 1977;105(5):488–495.
- Ozasa K. The effect of misclassification on evaluating the effectiveness of influenza vaccines. Vaccine 2008;26(50):6462–6465.
- Choi SC, Clifton GL, Marmarou A, Miller ER. Misclassification and treatment effect on primary outcome measures in clinical trials of severe neurotrauma. J Neurotrauma 2002;19(1):17–22.
- Lu J, Murray GD, Steyerberg EW, et al. Effects of Glasgow Outcome Scale misclassification on traumatic brain injury clinical trials. J Neurotrauma 2008;25(6):641–651.
- Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989;8(4):431–440.
- Hofman A, Breteler MM, van Duijn CM, et al. The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol 2009;24(9):553–572.
- Skenduli-Bala E, de Voogd S, Wolfs RC, et al. Causes of incident visual field loss in a general elderly population: the Rotterdam study. Arch Ophthalmol 2005;123(2):233–238.
- Czudowska MA, Ramdas WD, Wolfs RC, et al. Incidence of glaucomatous visual field loss: a ten-year follow-up from the Rotterdam Study. Ophthalmology 2010;117(9):1705–1712.
- Dielemans I, Vingerling JR, Hofman A, et al. Reliability of intraocular pressure measurement with the Goldmann applanation tonometer in epidemiological studies. Graefes Arch Clin Exp Ophthalmol 1994;232(3):141–144.
- Berger VW. Does the Prentice criterion validate surrogate endpoints? Stat Med 2004;23(10):1571–1578.
- Efron B. The jackknife, the bootstrap, and other resampling plans: Society for Industrial and Applied Mathematics, 1982.
- Harrell FE. Regression modelling strategies with applications to linear models, logistic regression, and survival analysis. New York: Springer-Verlag, 2001.
- Murphy EA, Abbey H. The normal range − a common misuse. J Chronic Dis 1967;20(2):79–88.
- Bourne RR, Sukudom P, Foster PJ, et al. Prevalence of glaucoma in Thailand: a population based survey in Rom Klao District, Bangkok. Br J Ophthalmol 2003;87(9):1069–1074.
- Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 2002;86(2):238–242.
- Ellenberg S, Hamilton JM. Surrogate endpoints in clinical trials: cancer. Stat Med 1989;8(4):405–413.
- Wittes J, Lakatos E, Probstfield J. Surrogate endpoints in clinical trials: cardiovascular diseases. Stat Med 1989;8(4):415–425.
- Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996;125(7):605–613.